Andrew Robbins
Vermögen: 23 Mio $ am 31.05.2026
Vermögen: 23 Mio $ am 31.05.2026
Andrew R.
Robbins is President, Chief Executive Officer & Director at Cogent Biosciences, Inc. since 2020.
Mr. Robbins is also an Independent Director at Turmeric Acquisition Corp.
since 2020.
Former roles include Independent Director at Harpoon Therapeutics, Inc. from 2020 to 2024; Chief Operating Officer at Array BioPharma, Inc. from 2015 to 2019; Senior Vice President-Commercial Operations at Pfizer Inc. from 2012 to 2015; General Manager & Vice President at Hospira, Inc. from 2007 to 2012; and Director positions at Cytograft Tissue Engineering, Inc., StemCor Systems, Inc., and Fate Therapeutics, Inc. Education includes undergraduate studies at Swarthmore College and an MBA from Kellogg School of Management.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
COGENT BIOSCIENCES, INC. 0,38 % | 19.05.2026 | 657.503 ( 0,38 % ) | 23 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| TURMERIC ACQUISITION CORP. | Direktor/Vorstandsmitglied | 01.10.2020 |
| COGENT BIOSCIENCES, INC. | Vorstandsvorsitzender | 23.10.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 11.03.2024 |
| ARRAY TECHNOLOGIES, INC. | Geschäftsführer | 01.01.2019 |
| PFIZER INC. | Geschäftsführer | 01.03.2015 |
| HOSPIRA, INC. | Corporate Officer/Principal | 01.07.2012 |
StemCor Systems, Inc.
StemCor Systems, Inc. Medical SpecialtiesHealth Technology Develops proprietary and minimally-invasive bone marrow collection systems | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Array BioPharma, Inc.
Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Hospira, Inc.
Hospira, Inc. Pharmaceuticals: MajorHealth Technology Provides drugs, IV sets and clinical integration & software, infusion pumps and implementation services | Health Technology |
Cytograft Tissue Engineering, Inc.
Cytograft Tissue Engineering, Inc. Pharmaceuticals: MajorHealth Technology Develops cardiovascular medicine | Health Technology |
StemCor Systems, Inc.
StemCor Systems, Inc. Medical SpecialtiesHealth Technology Develops proprietary and minimally-invasive bone marrow collection systems | Health Technology |
Cogent Biosciences, Inc.
Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Swarthmore College
Swarthmore College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harpoon Therapeutics, Inc.
Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
Turmeric Acquisition Corp.
Turmeric Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen